APO Research
Talk to an analyst

APO RESEARCH · REPORT

Decongestant

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Decongestant Industry Growth and Trends Forecast to 2032

31 December 202599 pages

Choose your research edition.

Industry ResearchDecongestant Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Decongestant Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Decongestant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decongestant Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Decongestant Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Decongestant market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Decongestant is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Decongestant is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Decongestant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Decongestant include Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Ranbaxy Laboratories Ltd., Cipla Ltd. and Beximco Pharmaceuticals Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Decongestant market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Decongestant market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Decongestant market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Decongestant.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Decongestant market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Decongestant Market by Company

Teva Pharmaceutical Industries Ltd.

Novartis AG

Mylan N.V.

Ranbaxy Laboratories Ltd.

Cipla Ltd.

Beximco Pharmaceuticals Ltd.

Decongestant Segment by Type

Nasal Sprays

Capsules

Tablets

Decongestant Segment by Application

Research & Academic Laboratories

Hospitals

Clinic

Other

Decongestant Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decongestant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decongestant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decongestant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Decongestant manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Decongestant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nasal Sprays Table 2. Major Company of Capsules Table 3. Major Company of Tablets Table 4. Global Decongestant Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Decongestant Sales by Type (2021-2026) & (K Units) Table 6. Global Decongestant Sales Market Share in Volume by Type (2021-2026) Table 7. Global Decongestant Sales by Type (2021-2026) & (US$ Million) Table 8. Global Decongestant Sales Market Share in Value by Type (2021-2026) Table 9. Global Decongestant Price by Type (2021-2026) & (US$/Unit) Table 10. Global Decongestant Sales by Type (2027-2032) & (K Units) Table 11. Global Decongestant Sales Market Share in Volume by Type (2027-2032) Table 12. Global Decongestant Sales by Type (2027-2032) & (US$ Million) Table 13. Global Decongestant Sales Market Share in Value by Type (2027-2032) Table 14. Global Decongestant Price by Type (2027-2032) & (US$/Unit) Table 15. North America Decongestant Sales by Type (2021-2026) & (K Units) Table 16. North America Decongestant Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Decongestant Sales by Type (2021-2026) & (K Units) Table 18. Europe Decongestant Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Decongestant Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Decongestant Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Decongestant Sales by Type (2021-2026) & (K Units) Table 22. Latin America Decongestant Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Decongestant Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Decongestant Sales by Type (2021-2026) & (US$ Million) Table 25. Decongestant Industry Trends Table 26. Decongestant Industry Drivers Table 27. Decongestant Industry Opportunities and Challenges Table 28. Decongestant Industry Restraints Table 29. Global Decongestant Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Decongestant Revenue Market Share by Company (2021-2026) Table 31. Global Decongestant Sales by Company (2021-2026) & (K Units) Table 32. Global Decongestant Sales Share by Company (2021-2026) Table 33. Global Decongestant Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Decongestant Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Decongestant Major Company Production Sites and Headquarters Table 36. Global Decongestant Company, Product Type & Application Table 37. Global Decongestant Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Decongestant by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Decongestant Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Decongestant Sales by Region (2021-2026) & (K Units) Table 42. Global Decongestant Sales Market Share in Volume by Region (2021-2026) Table 43. Global Decongestant Sales by Region (2021-2026) & (US$ Million) Table 44. Global Decongestant Sales Market Share in Value by Region (2021-2026) Table 45. Global Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Decongestant Sales by Region (2027-2032) & (K Units) Table 47. Global Decongestant Sales Market Share in Volume by Region (2027-2032) Table 48. Global Decongestant Sales by Region (2027-2032) & (US$ Million) Table 49. Global Decongestant Sales Market Share in Value by Region (2027-2032) Table 50. Global Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Decongestant Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Decongestant Sales by Application (2021-2026) & (K Units) Table 53. Global Decongestant Sales Market Share in Volume by Application (2021-2026) Table 54. Global Decongestant Sales by Application (2021-2026) & (US$ Million) Table 55. Global Decongestant Sales Market Share in Value by Application (2021-2026) Table 56. Global Decongestant Price by Application (2021-2026) & (US$/Unit) Table 57. Global Decongestant Sales by Application (2027-2032) & (K Units) Table 58. Global Decongestant Sales Market Share in Volume by Application (2027-2032) Table 59. Global Decongestant Sales by Application (2027-2032) & (US$ Million) Table 60. Global Decongestant Sales Market Share in Value by Application (2027-2032) Table 61. Global Decongestant Price by Application (2027-2032) & (US$/Unit) Table 62. North America Decongestant Sales by Application (2021-2026) & (K Units) Table 63. North America Decongestant Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Decongestant Sales by Application (2021-2026) & (K Units) Table 65. Europe Decongestant Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Decongestant Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Decongestant Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Decongestant Sales by Application (2021-2026) & (K Units) Table 69. Latin America Decongestant Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Decongestant Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Decongestant Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Pharmaceutical Industries Ltd. Company Information Table 73. Teva Pharmaceutical Industries Ltd. Business Overview Table 74. Teva Pharmaceutical Industries Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Teva Pharmaceutical Industries Ltd. Decongestant Product Portfolio Table 76. Teva Pharmaceutical Industries Ltd. Recent Development Table 77. Novartis AG Company Information Table 78. Novartis AG Business Overview Table 79. Novartis AG Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Novartis AG Decongestant Product Portfolio Table 81. Novartis AG Recent Development Table 82. Mylan N.V. Company Information Table 83. Mylan N.V. Business Overview Table 84. Mylan N.V. Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Mylan N.V. Decongestant Product Portfolio Table 86. Mylan N.V. Recent Development Table 87. Ranbaxy Laboratories Ltd. Company Information Table 88. Ranbaxy Laboratories Ltd. Business Overview Table 89. Ranbaxy Laboratories Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Ranbaxy Laboratories Ltd. Decongestant Product Portfolio Table 91. Ranbaxy Laboratories Ltd. Recent Development Table 92. Cipla Ltd. Company Information Table 93. Cipla Ltd. Business Overview Table 94. Cipla Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Cipla Ltd. Decongestant Product Portfolio Table 96. Cipla Ltd. Recent Development Table 97. Beximco Pharmaceuticals Ltd. Company Information Table 98. Beximco Pharmaceuticals Ltd. Business Overview Table 99. Beximco Pharmaceuticals Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Beximco Pharmaceuticals Ltd. Decongestant Product Portfolio Table 101. Beximco Pharmaceuticals Ltd. Recent Development Table 102. North America Decongestant Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. North America Decongestant Sales by Country (2021-2026) & (K Units) Table 104. North America Decongestant Sales Market Share by Country (2021-2026) Table 105. North America Decongestant Sales Forecast by Country (2027-2032) & (K Units) Table 106. North America Decongestant Sales Market Share Forecast by Country (2027-2032) Table 107. North America Decongestant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Decongestant Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Decongestant Market Share by Country (2021-2026) Table 110. North America Decongestant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Decongestant Market Share Forecast by Country (2027-2032) Table 112. Europe Decongestant Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Europe Decongestant Sales by Country (2021-2026) & (K Units) Table 114. Europe Decongestant Sales Market Share by Country (2021-2026) Table 115. Europe Decongestant Sales Forecast by Country (2027-2032) & (K Units) Table 116. Europe Decongestant Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Decongestant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Decongestant Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Decongestant Market Share by Country (2021-2026) Table 120. Europe Decongestant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Decongestant Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Decongestant Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Decongestant Sales by Country (2021-2026) & (K Units) Table 124. Asia-Pacific Decongestant Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Decongestant Sales Forecast by Country (2027-2032) & (K Units) Table 126. Asia-Pacific Decongestant Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Decongestant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Decongestant Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Decongestant Market Share by Country (2021-2026) Table 130. Asia-Pacific Decongestant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Decongestant Market Share Forecast by Country (2027-2032) Table 132. Latin America Decongestant Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Latin America Decongestant Sales by Country (2021-2026) & (K Units) Table 134. Latin America Decongestant Sales Market Share by Country (2021-2026) Table 135. Latin America Decongestant Sales Forecast by Country (2027-2032) & (K Units) Table 136. Latin America Decongestant Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Decongestant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Decongestant Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Decongestant Market Share by Country (2021-2026) Table 140. Latin America Decongestant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Decongestant Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Decongestant Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Decongestant Sales by Country (2021-2026) & (K Units) Table 144. Middle East and Africa Decongestant Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Decongestant Sales Forecast by Country (2027-2032) & (K Units) Table 146. Middle East and Africa Decongestant Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Decongestant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Decongestant Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Decongestant Market Share by Country (2021-2026) Table 150. Middle East and Africa Decongestant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Decongestant Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Decongestant Distributors List Table 155. Decongestant Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Decongestant Image Figure 2. Global Decongestant Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Decongestant Market Size (2021-2032) & (US$ Million) Figure 4. Global Decongestant Sales (2021-2032) & (K Units) Figure 5. Nasal Sprays Image Figure 6. Global Nasal Sprays Sales YoY Growth (2021-2032) & (K Units) Figure 7. Capsules Image Figure 8. Global Capsules Sales YoY Growth (2021-2032) & (K Units) Figure 9. Tablets Image Figure 10. Global Tablets Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Decongestant Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Decongestant Market Share by Type 2025 VS 2032 Figure 13. North America Decongestant Sales Market Share in Volume by Type in 2025 Figure 14. North America Decongestant Sales Market Share in Value by Type in 2025 Figure 15. Europe Decongestant Sales Market Share in Volume by Type in 2025 Figure 16. Europe Decongestant Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Decongestant Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Decongestant Sales Market Share in Value by Type in 2025 Figure 19. Latin America Decongestant Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Decongestant Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Decongestant Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Decongestant Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Decongestant Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Research & Academic Laboratories Image Figure 26. Global Research & Academic Laboratories Sales YoY Growth (2021-2032) & (K Units) Figure 27. Hospitals Image Figure 28. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Decongestant Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Decongestant Market Share by Application 2025 VS 2032 Figure 35. North America Decongestant Sales Market Share in Volume by Application in 2025 Figure 36. North America Decongestant Sales Market Share in Value by Application in 2025 Figure 37. Europe Decongestant Sales Market Share in Volume by Application in 2025 Figure 38. Europe Decongestant Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Decongestant Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Decongestant Sales Market Share in Value by Application in 2025 Figure 41. Latin America Decongestant Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Decongestant Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Decongestant Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Decongestant Sales Market Share in Value by Application in 2025 Figure 45. North America Decongestant Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Decongestant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Decongestant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Decongestant Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Decongestant Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Decongestant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Decongestant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Decongestant Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Decongestant Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Decongestant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Decongestant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Decongestant Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Decongestant Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Decongestant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Decongestant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Decongestant Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Decongestant Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Decongestant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Decongestant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Decongestant Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Decongestant Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Decongestant Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Sprays
  • Capsules
  • Tablets
Applications
  • Research & Academic Laboratories
  • Hospitals
  • Clinic
  • Other
Companies covered
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Mylan N.V.
  • Ranbaxy Laboratories Ltd.
  • Cipla Ltd.
  • Beximco Pharmaceuticals Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Decongestant Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Decongestant Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Decongestant Market by Type
  6. 1.3.1 Nasal Sprays
  7. 1.3.2 Capsules
  8. 1.3.3 Tablets
  9. 1.4 Global Decongestant Market Size by Type
  10. 1.4.1 Global Decongestant Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Decongestant Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Decongestant Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Decongestant Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Decongestant Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Decongestant Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Decongestant Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Decongestant Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Decongestant Industry Trends
  2. 2.2 Decongestant Industry Drivers
  3. 2.3 Decongestant Industry Opportunities and Challenges
  4. 2.4 Decongestant Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Decongestant Revenue (2021-2026)
  2. 3.2 Global Top Players by Decongestant Sales (2021-2026)
  3. 3.3 Global Top Players by Decongestant Price (2021-2026)
  4. 3.4 Global Decongestant Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Decongestant Major Company Production Sites & Headquarters
  6. 3.6 Global Decongestant Company, Product Type & Application
  7. 3.7 Global Decongestant Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Decongestant Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Decongestant Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Decongestant Tier 1, Tier 2, and Tier 3
4 Decongestant Regional Status and Outlook
  1. 4.1 Global Decongestant Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Decongestant Historic Market Size by Region
  3. 4.2.1 Global Decongestant Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Decongestant Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Decongestant Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Decongestant Forecasted Market Size by Region
  7. 4.3.1 Global Decongestant Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Decongestant Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Decongestant Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Decongestant by Application
  1. 5.1 Decongestant Market by Application
  2. 5.1.1 Research & Academic Laboratories
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinic
  5. 5.1.4 Other
  6. 5.2 Global Decongestant Market Size by Application
  7. 5.2.1 Global Decongestant Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Decongestant Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Decongestant Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Decongestant Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Decongestant Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Decongestant Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Decongestant Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Decongestant Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries Ltd.
  2. 6.1.1 Teva Pharmaceutical Industries Ltd. Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Ltd. Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Ltd. Decongestant Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Ltd. Decongestant Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Decongestant Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis AG Decongestant Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Mylan N.V.
  14. 6.3.1 Mylan N.V. Company Information
  15. 6.3.2 Mylan N.V. Business Overview
  16. 6.3.3 Mylan N.V. Decongestant Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan N.V. Decongestant Product Portfolio
  18. 6.3.5 Mylan N.V. Recent Developments
  19. 6.4 Ranbaxy Laboratories Ltd.
  20. 6.4.1 Ranbaxy Laboratories Ltd. Company Information
  21. 6.4.2 Ranbaxy Laboratories Ltd. Business Overview
  22. 6.4.3 Ranbaxy Laboratories Ltd. Decongestant Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ranbaxy Laboratories Ltd. Decongestant Product Portfolio
  24. 6.4.5 Ranbaxy Laboratories Ltd. Recent Developments
  25. 6.5 Cipla Ltd.
  26. 6.5.1 Cipla Ltd. Company Information
  27. 6.5.2 Cipla Ltd. Business Overview
  28. 6.5.3 Cipla Ltd. Decongestant Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cipla Ltd. Decongestant Product Portfolio
  30. 6.5.5 Cipla Ltd. Recent Developments
  31. 6.6 Beximco Pharmaceuticals Ltd.
  32. 6.6.1 Beximco Pharmaceuticals Ltd. Company Information
  33. 6.6.2 Beximco Pharmaceuticals Ltd. Business Overview
  34. 6.6.3 Beximco Pharmaceuticals Ltd. Decongestant Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Beximco Pharmaceuticals Ltd. Decongestant Product Portfolio
  36. 6.6.5 Beximco Pharmaceuticals Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Decongestant Sales by Country
  2. 7.1.1 North America Decongestant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Decongestant Sales by Country (2021-2026)
  4. 7.1.3 North America Decongestant Sales Forecast by Country (2027-2032)
  5. 7.2 North America Decongestant Market Size by Country
  6. 7.2.1 North America Decongestant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Decongestant Market Size by Country (2021-2026)
  8. 7.2.3 North America Decongestant Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Decongestant Sales by Country
  2. 8.1.1 Europe Decongestant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Decongestant Sales by Country (2021-2026)
  4. 8.1.3 Europe Decongestant Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Decongestant Market Size by Country
  6. 8.2.1 Europe Decongestant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Decongestant Market Size by Country (2021-2026)
  8. 8.2.3 Europe Decongestant Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Decongestant Sales by Country
  2. 9.1.1 Asia-Pacific Decongestant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Decongestant Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Decongestant Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Decongestant Market Size by Country
  6. 9.2.1 Asia-Pacific Decongestant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Decongestant Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Decongestant Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Decongestant Sales by Country
  2. 10.1.1 South America Decongestant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Decongestant Sales by Country (2021-2026)
  4. 10.1.3 South America Decongestant Sales Forecast by Country (2027-2032)
  5. 10.2 South America Decongestant Market Size by Country
  6. 10.2.1 South America Decongestant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Decongestant Market Size by Country (2021-2026)
  8. 10.2.3 South America Decongestant Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Decongestant Sales by Country
  2. 11.1.1 Middle East and Africa Decongestant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Decongestant Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Decongestant Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Decongestant Market Size by Country
  6. 11.2.1 Middle East and Africa Decongestant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Decongestant Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Decongestant Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Decongestant Value Chain Analysis
  2. 12.1.1 Decongestant Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Decongestant Production Mode & Process
  7. 12.2 Decongestant Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Decongestant Distributors
  10. 12.2.3 Decongestant Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst